Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidiabetic effects of adding sitagliptin to existing liraglutide + metformin therapy in type 2 diabetes
2013-001764-35Phase 3Completed
- Sponsor
- Diabeteszentrum Bad Lauterberg im Harz
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Diabeteszentrum Bad Lauterberg im Harz. Primary endpoint: Incremental area under the plasma glucose concentration-time profile (AUC). Started Aug 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-001764-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001764-35.